2022
DOI: 10.1093/hmg/ddac181
|Get access via publisher |Summarize |Cite|
|
Sign up to set email alerts

AAV-mediated gene-replacement therapy restores viability of BCD patient iPSC derived RPE cells and vision of Cyp4v3 knockout mice

Abstract: Bietti crystalline corneoretinal dystrophy (BCD) is an autosomal recessive retinal degenerative disease characterized by yellow-white crystal deposits in the posterior pole, degeneration of the retinal pigment epithelium (RPE), and sclerosis of the choroid. Mutations in the cytochrome P450 4 V2 gene (CYP4V2) cause BCD, which is associated with lipid metabolic disruption. The use of gene replacement therapy in BCD has been hampered by the lack of disease models. To advance CYP4V2 gene replacement therapy, we ge… Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
16
3
1
1

Citation Types

0
10
0
0

Year Published

Range
2024
2024
2026
2026

Publication Types

Select...
16
2
1

Relationship

2
17

Authors

Journals

citations

Cited by 19 publications

(10 citation statements)
references

References 45 publications

0
10
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…smFISH confirmed OE-specific expression of Cyp4v3 (Fig. 2F), a member of the cytochrome P450 family, which participated in lipid metabolism and steroid hormone biosynthesis (Jia et al, 2023). Cldn9, encoding a tight junction protein, may contribute to olfactory epithelium barrier integrity (Nakano et al, 2009;Bird et al, 2010).…”
Section: Molecular Characterization Of the Embryonic Nasal Epithelium
mentioning
confidence: 82%